CURRICULUM VITAE Miriam Fernández Suárez, Psy. D.
1995 Road 2 Suite 1209-1210 Bayamón, Puerto Rico 00959-1201
Fax: (787) 787-0412 Cellular: (787) 216-2242
Medical Licenses Puerto Rico: Academic History
2000
Centro Caribeño de Estudios Post Graduados, University Pedro Albizu San Juan, Puerto Rico Doctor’s Degree Clinical Psychology
Servicios Psicológicos y Consultivos, Inc (SPICI), Humacao, Puerto Rico Internship in Clinical Psychology
Centro Caribeño de Estudios Post Graduados, Clínica de la Comunidad, San Juan, Puerto Rico Clinical Psychology Practice
Publications 2000
The design of a Curriculum for a Doctor’s Degree specialized in Gerontology in Puerto Rico.
Experience
Caribbean Education and Research Center,
Bayamón, Puerto Rico Independent Rater Psychological Evaluations
Centro Especializado en Psiquiatría, Bayamón, Puerto Rico Private Practice
Medical Psychiatric Center, Carolina Puerto Rico Private Practice
Clínica Dr. Padró & Asociados, Guaynabo, Puerto Rico Psychologist Coordinator Coodinator for Primary Services in Partial Hospitalization, Ambulatory Program and Speaker for Psychological-Educational directed to Factories.
Servicios Psicologicos Integrales, Inc., Humacao, Puerto Rico Psychologist Services to Victims of Crimes, Domestic Violence and Sexual Abuse
Department of Education, San Juan, Puerto Rico Psychologist and Clinical Consultant Psychological Services and consultation to High Schools for the Multi-strategy for a Superior Education Program
Centro Caribeño de Estudios Post Graduados, San Juan, Puerto Rico Clinical Supervisor Supervision of Students in Module II-IV
Research
An 8-week, randomized, double-blind, placebo-controlled,
parallel-group, multi-center study of the efficacy and safety of
agomelatine 0.5 mg and 1mg sublingual tablets administered
once daily in patients with Major Depressive Disorder (MDD) Sub-Investigator
A 52-Week, multi-center, open-label study of the safety and
tolerability of agomelatine sublingual tablets in patients with
Novartis A 24 Week Open-Label Extension to Study CENA713DSU44:
A 24 Week, Prospective, Randomized, Parallel-Group,
Double-Blind, Multi-Center Study Comparing the Effects of
Rivastigmine Patch 15cm2 Vs. Rivastigmine Patch 5 cm2 on
ACTivities of Daily Living and CognitION in Patients with
Severe Dementia of the Alzheimer’s Type (ACTION).
A 24 Week, Prospective, Randomized, Parallel-Group,
Double-Blind, Multi Center Study Comparing the Effects of
Rivastigmine Patch 15cm2 vs. Rivastigmine Patch 5cm2 on
Activities of Daily Living and Cognition in Patients with Severe Dementia of the Alzheimer’s Type. Independent Rater
Instituto Latinoamericano, Inc. Guaynabo, Puerto Rico Consultant Investigation and Statistics on Educations Services for Patients and Family Members
RECOPE, Humacao, Puerto Rico Investigator Investigation Based on Clinical Evaluations of the profile and conduct on Mistreated Women.
Consultores Psicológicos y Psicoeducativos, Hato Rey, Puerto Rico Investigation Consultant Investigations Profiles of Adolescents Diagnosed with Antisocial Personality Disorder
Department of Justice, Humacao, Puerto Rico Consultant Investigation and consultation for Crime Victims
Texto de la Ficha Técnica común a todas las especialidades farmacéuticas que contienen Cerivastatina RESUMEN DE CARACTERÍSTICAS DEL PRODUCTO MARCAS/TITULAR DE LAS ESPECIALIDADES Laboratorio titular COMPOSICIÓN CUALITATIVA Y CUANTITATIVA + FORMA FARMACÉUTICA • 1 comprimido de cerivastatina 0,1 mg contiene 95,4 microgramos (mcg) de cerivastatina (DCI); equival
ReviewOLFACTORY REFERENCE SYNDROME: ISSUES FOR DSM-VJamie D. Feusner, M.D.,1Ã Katharine A. Phillips, M.D.,2 and Dan J. Stein, M.D. Ph.D.3The published literature on olfactory reference syndrome (ORS) spans morethan a century and provides consistent descriptions of its clinical features. Thecore symptom is preoccupation with the belief that one emits a foul or offensivebody odor, which is not pe